Trial Profile

A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bosutinib (Primary)
Indications Breast cancer; Myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma; Solid tumours
Focus Pharmacokinetics
Sponsors Wyeth

Most Recent Events

30 Jul 2010 Actual initiation date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
30 Jul 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
30 Jul 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.`

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com